trimetazidine has been researched along with atorvastatin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bhonde, R; Govindasamy, V; Mamidi, MK; Pal, R; Zakaria, Z | 1 |
| Grabowski, T; Jaroszewski, JJ; Sasinowska-Motyl, M | 1 |
| Cui, W; Du, H; Hao, J; Li, WW; Liu, F; Lu, JC; Yang, XC; Zhao, ZF | 1 |
1 trial(s) available for trimetazidine and atorvastatin
| Article | Year |
|---|---|
Effects of atorvastatin combined with trimetazidine on myocardial injury and inflammatory mediator in unstable angina patients during perioperative of percutaneous coronary intervention.
Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Combined Modality Therapy; Drug Therapy, Combination; Female; Heart Injuries; Humans; Inflammation Mediators; Interferon-gamma; Male; Middle Aged; Percutaneous Coronary Intervention; Perioperative Period; Postoperative Complications; Trimetazidine; Troponin I; Tumor Necrosis Factor-alpha | 2015 |
3 other study(ies) available for trimetazidine and atorvastatin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Treat the graft to improve the regenerative ability of the host.
Topics: Atorvastatin; Cell Survival; Diazoxide; Heptanoic Acids; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Pyrroles; Regeneration; Regenerative Medicine; Transplants; Trimetazidine | 2011 |
Leave-one-out procedure in the validation of elimination rate constant analysis.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Antifungal Agents; Atorvastatin; Dosage Forms; Drug Design; Female; Half-Life; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Itraconazole; Male; Middle Aged; Perindopril; Pharmaceutical Preparations; Pharmacokinetics; Pyrroles; Reproducibility of Results; Therapeutic Equivalency; Trimetazidine; Vasodilator Agents; Young Adult | 2012 |